Adding a long‑acting local anesthetic to a steroid injection after arthroscopic rotator cuff repair for shoulder adhesion
Official title: Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial
Run by Second Affiliated Hospital of Nanchang University · NCT07348016 · Data updated 2026-11-12
We will test whether adding liposomal bupivacaine to a standard intra‑articular steroid injection helps adults having arthroscopic rotator cuff repair with shoulder adhesion have less pain and better shoulder function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Second Affiliated Hospital of Nanchang University Academic / other |
| Locations | 1 site (Nanchang, Jiangxi) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | July 30, 2027 |
| Study ends | December 1, 2028 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT07348016 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with MRI‑confirmed full‑thickness rotator cuff tear and concomitant shoulder adhesion who are scheduled for arthroscopic repair and capsular release and can consent and attend follow‑up are ideal candidates.
✕Probably not a fit
Patients with massive irreparable tears, severe glenohumeral osteoarthritis, prior shoulder infection or surgery on the affected side, allergies to the study drugs, systemic inflammatory arthritis, or bleeding disorders are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, double‑blind, parallel‑group trial enrolling about 70 adults with full‑thickness rotator cuff tear and shoulder adhesion undergoing arthroscopic repair and capsular release. Participants are randomized to receive either a combination injection of liposomal bupivacaine plus compound betamethasone or compound betamethasone alone into the joint at the end of surgery. Patients and outcome assessors are blinded, and follow‑up visits occur through 12 months with assessments at multiple time points. The primary outcome is the UCLA Shoulder Score, with secondary outcomes including VAS pain scores, Constant‑Murley score, active range of motion, MRI tendon healing (SNQ), and complication rates.
Why it matters
Potential benefit: If successful, the combination injection could reduce postoperative pain and stiffness and improve recovery of shoulder function after rotator cuff repair.
How similar studies have gone: Previous work on liposomal bupivacaine for postoperative shoulder pain has reported mixed results and combining intra‑articular steroids is common but not definitively proven for preventing adhesion‑related stiffness, so this specific combination is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age between 18 and 70 years. Clinical and MRI diagnosis of full-thickness rotator cuff tear. Presence of shoulder stiffness/adhesion defined as passive range of motion less than 100° in forward flexion and/or less than 10° in external rotation (or according to your specific definition). Scheduled for arthroscopic rotator cuff repair and capsular release. Willing and able to provide written informed consent. Willing to comply with all study procedures and follow-up visits. Exclusion Criteria : Massive, irreparable rotator cuff tear. Severe glenohumeral osteoarthritis (Grade III or IV according to Samilson-Prieto classification). History of shoulder infection, fracture, or previous surgery on the affected shoulder. Known allergy or contraindication to betamethasone, local anesthetics, or components of PRP preparation. Systemic inflammatory arthritis (e.g., rheumatoid arthritis). Coagulation disorders or use of anticoagulants that cannot be safely suspended perioperatively. Pregnancy or lactation. Participation in another clinical trial within the past 3 months. Any medical or psychiatric condition that, in the investigator's opinion, would compromise patient safety or compliance with the study protocol.
Where it's running
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China Recruiting
Study contacts
- Study coordinator: Hao Liang, MD
- Email: haoliang201@163.com
- Phone: +86-13607008562
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotator cuff repair with biceps rerouting and dermal graft augmentation for large, difficult tears
This study tests a combined surgical approach to see if it helps tendon retear rates in adults with large rotator cuff tears that are hard to repair.
-
Muscle Thickness, Trunk Proprioception, and Postural Stability in Rotator Cuff Pathology
This study tests whether trunk and abdominal muscle thickness and sense of position relate to shoulder problems from rotator cuff issues, by comparing people with rotator cuff pathology to healthy controls.
-
Single-shot nerve block with IV dexamethasone for rebound pain after shoulder surgery
This trial tests whether giving a one-time shoulder nerve block plus an IV dexamethasone dose can prevent rebound pain after shoulder surgery.
-
Two anesthesia methods to keep the joint clear during shoulder arthroscopy
This trial tests whether inhaled sevoflurane vs. total intravenous anesthesia with propofol affects how well surgeons can see inside the shoulder during rotator cuff repair.
-
Concentric vs Eccentric Full Can Exercise for Partial Rotator Cuff Tears
This study tests whether concentric or eccentric full can exercises are more effective for improving shoulder pain and muscle structure in people with partial rotator cuff tears.
-
Tracking recovery after arthroscopic shoulder and knee surgeries
This will follow people having routine arthroscopic shoulder or knee surgery to see if patient characteristics, tear details, or surgical choices predict better recovery and function over two years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.